The value of a multidisciplinary approach in the management of gastric cancer.

[1]  W. Allum,et al.  Programme for early detection of gastric cancer. , 1986, British medical journal.

[2]  S. Levitt,et al.  Extrapelvic colon--areas of failure in a reoperation series: implications for adjuvant therapy. , 1985, International journal of radiation oncology, biology, physics.

[3]  H. Maartmann-Moe,et al.  On the reputed decline in gastric carcinoma: necropsy study from western Norway. , 1985, British medical journal.

[4]  C. Roginski,et al.  Clinicopathological staging of gastric cancer , 1984, The British journal of surgery.

[5]  K. Inoue,et al.  [Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate]. , 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[6]  M. O’connell.  A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma , 1982, Cancer.

[7]  L. Gunderson,et al.  Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. , 1982, International journal of radiation oncology, biology, physics.

[8]  J. Waterhouse,et al.  The West Midlands gastric carcinoma chemotherapy trial: planning and results. , 1978, Clinical oncology.

[9]  B. Petrini,et al.  Failure to demonstrate tumour-specific leucocyte migration inhibition in vitro by cryostat sections of breast cancer tissue. , 1977, Clinical oncology.

[10]  S. Fujimoto,et al.  Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. , 1977, Annals of surgery.

[11]  C. Moertel,et al.  Sequential and combination chemotherapy of advanced gastric cancer , 1976, Cancer.

[12]  J. Kovach,et al.  A controlled study of combined 1,3‐bis‐(2‐chloroethyl)‐1‐nitrosourea and 5‐fluorouracil therapy for advanced gastric and pancreatic cancer , 1974 .